SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sunderland, T.
Right arrow Articles by Cohen, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sunderland, T.
Right arrow Articles by Cohen, R. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Alzheimer's Disease
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?

Trey Sunderland, MD

Geriatric Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, trey{at}mail.nih.gov

Harald Hampel, MD

Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany

Masatoshi Takeda, MD, PhD

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Karen T. Putnam, MS

Litwin-Zucker Research Center, North Shore-LIJ Health System, Great Neck, New York

Robert M. Cohen, MD, PhD

Department of Psychiatry, Cedars-Sinai Medical Center, Los Angeles, California

Although clinical manifestations of cognitive dysfunction and impairments of activities of daily living are the current standard measures for the diagnosis of Alzheimer’s disease, biomarkers are receiving increasing attention in research centers as possible early diagnostic measures or as surrogate measures of the ongoing pathology. In preparation for the upcoming development of the Diagnostic and Statistical Manual of Mental Disorders (5th ed; DSM-V) nosology, the American Psychiatric Association has sponsored an effort to reassess the current approaches to diagnosis in dementia in general and Alzheimer’s disease in particular. This article focuses on the potential use of biomarkers in the diagnosis of Alzheimer’s disease, in the monitoring of mild cognitive impairment, and as possible prognostic markers in normal controls at risk for dementia. Most advanced information is available with the biomarkers found in the cerebrospinal fluid, but there are many other potential biomarkers using blood, brain imaging, or a combination. The current biomarker approaches to diagnosis are reviewed along with a special emphasis on near-term recommendations and further research directions. (J Geriatr Psychiatry Neurol 2006;19:172-179)

Key Words: biomarkers • Alzheimer’s disease • cerebrospinal fluid • sensitivity and specificity • diagnosis

Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 3, 172-179 (2006)
DOI: 10.1177/0891988706291088


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
A. Frances
Whither DSM-V?
The British Journal of Psychiatry, November 1, 2009; 195(5): 391 - 392.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Woodard, M. Seidenberg, K. A. Nielson, P. Antuono, L. Guidotti, S. Durgerian, Q. Zhang, M. Lancaster, N. Hantke, A. Butts, et al.
Semantic memory activation in amnestic mild cognitive impairment
Brain, August 1, 2009; 132(8): 2068 - 2078.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
American Journal of Alzheimer's Disease and Other Dementias, April 1, 2009; 24(2): 95 - 121.
[Abstract] [PDF]


Home page
Epidemiol RevHome page
J. J. Jalbert, L. A. Daiello, and K. L. Lapane
Dementia of the Alzheimer Type
Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. K. Kauwe, C. Cruchaga, K. Mayo, C. Fenoglio, S. Bertelsen, P. Nowotny, D. Galimberti, E. Scarpini, J. C. Morris, A. M. Fagan, et al.
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
PNAS, June 10, 2008; 105(23): 8050 - 8054.
[Abstract] [Full Text] [PDF]



Advertisement